本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

TELA Bio, Inc.

1.99
-0.0200-1.00%
盘后2.080.0900+4.52%18:36 EDT
成交量:6.06万
成交额:12.17万
市值:7,871.40万
市盈率:-1.54
高:2.16
开:2.04
低:1.95
收:2.01
数据加载中...
2024/07/02

超过5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/10

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/06/06

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/15

重要事件披露

Form 8-K - Current report
2024/03/22

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/17

SEC问询函

Form CORRESP - Correspondence
2023/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/10

重要事件披露

Form 8-K - Current report
2023/10/21

重要事件披露

Form 8-K - Current report
2023/10/06

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals